MJALLI ADNAN M M,BEHME CHRISTOPHER,CHRISTEN DANIEL P,POLISETTI DHARMA RAO,QUADA JAMES,FREEMAN JENNIFER L R,SANTHOSH KALPATHY,BONDLELA MURALIDHAR,GUZEL MUSTAFA,YARRAGUNTA RAVINDRA REDDY,GOHIMUKKULA DEV
申请号：
IN6636/DELNP/2011
公开号：
IN2011DN06636A
申请日:
2011.08.30
申请国别(地区):
IN
年份:
2012
代理人:
摘要：
The present invention is directed to substituted azoanthracene derivatives or pharmaceutically acceptable salts thereof that modulate the human GLP-1 receptor and that may be useful in the treatment of diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial, such as diabetes mellitus type 2. The invention is also directed to pharmaceutical compositions comprising these compounds and to the use of these compounds and compositions in the treatment of such diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial.
